Casale G P, Singhal M, Bhattacharya S, RamaNathan R, Roberts K P, Barbacci D C, Zhao J, Jankowiak R, Gross M L, Cavalieri E L, Small G J, Rennard S I, Mumford J L, Shen M
Eppley Institute for Research in Cancer, 986805, University of Nebraska Medical Center, Omaha, Nebraska 68198-6805, USA.
Chem Res Toxicol. 2001 Feb;14(2):192-201. doi: 10.1021/tx000012y.
Polycyclic aromatic hydrocarbons (PAH) are metabolized to electrophiles that can bind to DNA bases and destabilize the N-glycosyl bond, causing rapid depurination of the adducted bases. Recent studies support depurination of DNA as a mechanism central to the genesis of H-ras mutations in PAH-treated mouse skin. Depurinating adducts account for 71% of all DNA adducts formed in mouse skin treated with benzo[a]pyrene (BP). This study analyzed urine of cigarette smokers, coal smoke-exposed women, and nonexposed controls for the presence and quantities of the depurinated BP-adducted DNA bases, 7-(benzo[a]pyren-6-yl)guanine (BP-6-N7Gua) and 7-(benzo[a]pyren-6-yl)adenine (BP-6-N7Ade). Since these adducted bases originate from reaction of the BP radical cation with double-stranded DNA and not with RNA or denatured DNA, their presence in urine is indicative of DNA damage. Urine samples were fractionated by a combination of SepPak extraction and reverse-phase HPLC, and then analyzed by tandem mass spectrometry and capillary electrophoresis with laser-induced fluorescence. BP-adducted bases were detected in the urine from three of seven cigarette smokers and three of seven women exposed to coal smoke, but were not detected in urine from the 13 control subjects. Concentrations were estimated to be 60-340 and 0.1-0.6 fmol/mg of creatinine equivalent of urine for coal smoke-exposed women (maximum possible BP intake of ca. 23 000 ng/day) and cigarette smokers (BP intake of ca. 800 ng/day), respectively, exhibiting a sensitive response to BP exposures. BP-6-N7Gua was present at ca. 20-300 times the concentration of BP-6-N7Ade in the urine of coal smoke-exposed women, but was not detected in the urine of cigarette smokers. This difference may be due to the remarkably different BP exposures experienced by the two groups of PAH-exposed individuals. These results justify more extensive studies of depurinated BP-adducted DNA bases as potential biomarkers of PAH-associated cancer risk.
多环芳烃(PAH)可代谢生成亲电试剂,这些亲电试剂能与DNA碱基结合并破坏N - 糖苷键的稳定性,导致加合碱基快速脱嘌呤。最近的研究支持DNA脱嘌呤是PAH处理的小鼠皮肤中H - ras基因突变发生机制的核心。在经苯并[a]芘(BP)处理的小鼠皮肤中形成的所有DNA加合物中,脱嘌呤加合物占71%。本研究分析了吸烟者、接触煤烟的女性以及未接触者的尿液中脱嘌呤的BP加合DNA碱基7 -(苯并[a]芘-6 - 基)鸟嘌呤(BP - 6 - N7Gua)和7 -(苯并[a]芘-6 - 基)腺嘌呤(BP - 6 - N7Ade)的存在情况和数量。由于这些加合碱基源自BP自由基阳离子与双链DNA的反应,而非与RNA或变性DNA的反应,它们在尿液中的存在表明DNA受到了损伤。尿液样本通过SepPak萃取和反相高效液相色谱相结合的方法进行分离,然后通过串联质谱和激光诱导荧光毛细管电泳进行分析。在7名吸烟者中的3名以及7名接触煤烟的女性中的3名的尿液中检测到了BP加合碱基,但在13名对照受试者的尿液中未检测到。对于接触煤烟的女性(最大可能的BP摄入量约为23000 ng/天)和吸烟者(BP摄入量约为800 ng/天),估计其浓度分别为60 - 340和0.1 - 0.6 fmol/mg肌酐当量的尿液,显示出对BP暴露的敏感反应。在接触煤烟的女性尿液中,BP - 6 - N7Gua的浓度约为BP - 6 - N7Ade的20 - 300倍,但在吸烟者的尿液中未检测到BP - 6 - N7Ade。这种差异可能是由于两组PAH暴露个体所经历的BP暴露显著不同。这些结果证明有必要对脱嘌呤的BP加合DNA碱基作为PAH相关癌症风险的潜在生物标志物进行更广泛的研究。